This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: New York University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nathan Beals: Innovator in Drug Conjugates
Introduction
Nathan Beals is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of drug development, particularly through his innovative work at New York University. His research focuses on enhancing drug delivery systems, which can lead to more effective treatments for various diseases.
Latest Patents
Nathan Beals holds a patent for "Macropinocytosis Selective Monobody-Drug Conjugates." This invention represents a breakthrough in targeted drug delivery, allowing for more precise treatment options. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Nathan has been dedicated to research and innovation. His work at New York University has positioned him as a key figure in the development of new therapeutic strategies. His contributions have the potential to impact patient care significantly.
Collaborations
Nathan collaborates with Andrew Hauser, a fellow researcher at New York University. Together, they explore new avenues in drug development, combining their expertise to push the boundaries of current medical practices.
Conclusion
Nathan Beals is an influential inventor whose work in drug conjugates is paving the way for advancements in targeted therapies. His dedication to research and collaboration highlights the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile